Bursch Laura S, Wang Liangchun, Igyarto Botond, Kissenpfennig Adrien, Malissen Bernard, Kaplan Daniel H, Hogquist Kristin A
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
J Exp Med. 2007 Dec 24;204(13):3147-56. doi: 10.1084/jem.20071966. Epub 2007 Dec 17.
Langerhans cells (LCs) are antigen-presenting cells that reside in the epidermis of the skin and traffic to lymph nodes (LNs). The general role of these cells in skin immune responses is not clear because distinct models of LC depletion resulted in opposite conclusions about their role in contact hypersensitivity (CHS) responses. While comparing these models, we discovered a novel population of LCs that resides in the dermis and does not represent migrating epidermal LCs, as previously thought. Unlike epidermal LCs, dermal Langerin(+) dendritic cells (DCs) were radiosensitive and displayed a distinct cell surface phenotype. Dermal Langerin(+) DCs migrate from the skin to the LNs after inflammation and in the steady state, and represent the majority of Langerin(+) DCs in skin draining LNs. Both epidermal and dermal Langerin(+) DCs were depleted by treatment with diphtheria toxin in Lang-DTREGFP knock-in mice. In contrast, transgenic hLang-DTA mice lack epidermal LCs, but have normal numbers of dermal Langerin(+) DCs. CHS responses were abrogated upon depletion of both epidermal and dermal LCs, but were unaffected in the absence of only epidermal LCs. This suggests that dermal LCs can mediate CHS and provides an explanation for previous differences observed in the two-model systems.
朗格汉斯细胞(LCs)是驻留在皮肤表皮并迁移至淋巴结(LNs)的抗原呈递细胞。这些细胞在皮肤免疫反应中的总体作用尚不清楚,因为不同的LC耗竭模型对其在接触性超敏反应(CHS)中的作用得出了相反的结论。在比较这些模型时,我们发现了一种新的LC群体,它们存在于真皮中,并不像之前认为的那样代表迁移的表皮LC。与表皮LC不同,真皮中的朗格凝集素阳性树突状细胞(DCs)对辐射敏感,并表现出独特的细胞表面表型。真皮中的朗格凝集素阳性DCs在炎症后和稳态下从皮肤迁移至LNs,并且在引流皮肤的LNs中占朗格凝集素阳性DCs的大多数。在Lang-DTREGFP基因敲入小鼠中,用白喉毒素处理可使表皮和真皮中的朗格凝集素阳性DCs均耗竭。相比之下,转基因hLang-DTA小鼠缺乏表皮LC,但真皮中朗格凝集素阳性DCs数量正常。当表皮和真皮中的LC均被耗竭时,CHS反应被消除,但仅缺乏表皮LC时则不受影响。这表明真皮LC可以介导CHS,并为之前在两种模型系统中观察到的差异提供了解释。
J Exp Med. 2007-12-24
J Exp Med. 2007-12-24
J Invest Dermatol. 2010-8-12
J Immunol. 2010-9-20
Pathogens. 2025-5-9
Nat Commun. 2025-2-26
Front Immunol. 2023
Proc Natl Acad Sci U S A. 2023-8-22
J Immunol Methods. 2007-7-31
Nat Immunol. 2006-3